Authors:
Mesa, AV
Norman, A
Solberg, TD
Demarco, JJ
Smathers, JB
Citation: Av. Mesa et al., Dose distributions using kilovoltage x-rays and dose enhancement from iodine contrast agents, PHYS MED BI, 44(8), 1999, pp. 1955-1968
Authors:
Grill, V
Persson, G
Carlsson, S
Norman, A
Alvarsson, M
Ostensson, CG
Svanstrom, L
Efendic, S
Citation: V. Grill et al., Family history of diabetes in middle-aged Swedish men is a gender unrelated factor which associates with insulinopenia in newly diagnosed diabetic subjects, DIABETOLOG, 42(1), 1999, pp. 15-23
Authors:
Waters, JS
Norman, A
Cunningham, D
Scarffe, JH
Webb, A
Harper, P
Joffe, JK
Mackean, M
Mansi, J
Leahy, M
Hill, A
Oates, J
Rao, S
Nicolson, M
Hickish, T
Citation: Js. Waters et al., Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial, BR J CANC, 80(1-2), 1999, pp. 269-272
Authors:
Assersohn, L
Norman, A
Cunningham, D
Benepal, T
Ross, PJ
Oates, J
Citation: L. Assersohn et al., Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma, BR J CANC, 79(11-12), 1999, pp. 1800-1805
Authors:
Hickish, TF
Smith, IE
Nicolson, MC
Ashley, S
Priest, K
Spencer, L
Norman, A
Middleton, G
O'Brien, MER
Citation: Tf. Hickish et al., A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapyin small-cell lung cancer, BR J CANC, 77(11), 1998, pp. 1966-1970